Can a smart glucose monitor improve diabetes care? new trial aims to find out.

NCT ID NCT05633628

Recruiting now Disease control Sponsor: Sophiahemmet University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using a continuous glucose monitor (CGM) for short periods, combined with personalized feedback, helps adults with type 2 diabetes control their blood sugar better than standard finger-prick testing. About 400 participants will be randomly assigned to either periodic CGM or usual self-monitoring. The main goal is to see if HbA1c levels improve over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: continuous glucose monitoring (CGM) device
What this could lead to: If successful, this could show that periodic CGM with personalized feedback helps people with type 2 diabetes better manage their blood sugar levels.
What could go wrong: This is a behavioral intervention study, not a drug trial, so the effect may be modest. Results depend on patient engagement and may not apply to everyone with type 2 diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES

Contacts and locations

Locations

Sophiahemmet University
RECRUITING

Stockholm, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.